Mylan wins FDA approval for trandolapril tablets - Pharmaceutical Business review

29 Apr 2008

Mylan wins FDA approval for trandolapril tablets

Mylan Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application for trandolapril tablets, 1mg, 2mg and 4mg.

Trandolapril tablets are the generic version of Abbott’s Mavik tablets, which are indicated for the treatment of hypertension.

Drug Discovery